RECENT NEWS

The Royal College of Pathologists (RCPath) is marking International Pathology Day this year on Wednesday 6 November with a day-long virtual conference looking at the issue of antimicrobial resistance (AMR).

The final stages of recovery following the cyber attack on pathology services provider Synnovis in June are almost complete, which means nearly all services are now up and running.

The Medicines and Healthcare products Regulatory Agency (MHRA) has launched its ambitious new business plan for 2024/25, setting out the agency’s core focus of enabling access to innovative healthcare products while ensuring delivery for all who need its services – patients and the public, healthcare professionals, researchers and developers.

Italian microsopy manufacturer CrestOptics and Leica Microsystems have announced a new collaboration, bringing CrestOptics’ CICERO spinning disk unit technology to Leica Microsystems’ new THUNDER Imager Cell Spinning Disk system.

Netherlands-based diagnostic firm QIAGEN has announced the launch of the QIAcuityDx Digital PCR System, a new addition to its digital PCR portfolio which is expanding into clinical diagnostics. The new system streamlines clinical testing by providing highly precise, absolute quantitation of target DNA and RNA, supporting applications with less invasive liquid biopsies.

Clinicians working at five of the six NHS Trusts in the West Yorkshire Association of Acute Trusts (WYAAT) can access pathology and other diagnostic test results from across their network, following a summer roll-out of Clinisys’ ICE OpenNet.

Digital pathology firm Proscia has announced the launch of Concentriq Embeddings and the Proscia AI Toolkit, enabling life sciences organisations to accelerate the discovery and development of novel therapies and diagnostics.

Hundreds of babies have begun to be tested for over 200 rare genetic conditions as part of a world-leading study in NHS hospitals that aims to screen up to 100,000 newborns in England.

Beckman Coulter Life Sciences has announced the appointment of Joe Fox as President of the company, effective immediately.

A new white paper report commissioned by Abbott seeks to provide a constructive contribution to ongoing policy and legislative developments for medical devices and diagnostics. Its release comes as the new UK Government looks to refocus healthcare more towards prevention and closer to home through the use of the latest innovative technologies, and with a focus on regulatory innovation.

Research led by scientists at Queen Mary University of London is heralding in a new era for genetic sequencing and testing.

BioAI, a biotechnology company applying multimodal artificial intelligence (AI) to novel biomarker discovery, development, and diagnostics, has announced a strategic partnership with Arbele, a biopharmaceutical company dedicated to developing novel immunotherapeutic platforms for gastrointestinal cancers.

A collaborative research team led by Professor Chulhong Kim and Professor Chan Kwon Jung of Seoul St. Mary’s Hospital, Catholic University of Korea, has developed an artificial intelligence (AI) system to analyse the label-free photoacoustic histological images of human liver cancer tissues.

AI-powered pathology solutions provider Mindpeak has announced it has raised $15.3 million in a Series A funding round. This new investment will enable the company to further expand the commercialisation of its recently expanded suite of technologies across several new territories.

‘Breath biopsy’ firm Owlstone Medical has announced it has entered into a Research Collaboration Agreement with the US FDA’s Center for Devices and Radiological Health (CDRH) - Office of Science and Engineering Laboratories (OSEL). The goal of the collaboration is to develop methods for the confident identification of individual chemicals in the complex mixture of breath.

The Royal College of Pathologists (RCPath) has published a new Patient Safety and Quality Strategy as part of its ongoing aim to improve patient safety.

Global leaders have approved a political declaration at the 79th United Nations General Assembly (UNGA) High-Level Meeting on Antimicrobial Resistance (AMR), committing to a clear set of targets and actions, including reducing the estimated 4.95 million human deaths associated with bacterial antimicrobial resistance (AMR) annually by 10% by 2030.

Government-led negotiations on the world’s first agreement to protect people from future pandemics made significant progress during the latest round of discussions that ended recently at the World Health Organization (WHO).

Diagnostic firm Cepheid has announced a new partnership with the Fleming Initiative, a global collaboration established by Imperial College Healthcare NHS Trust and Imperial College London to combat antimicrobial resistance (AMR).

Two newly published Alzheimer’s studies reveal details of the disease’s biology, risk for progression, and the potential for a novel blood test.